Blum Robert I's Form 4 filing
Cytokinetics Inc (CYTK) · filed Jul 14, 2026
- Accession no.
- 0001061983-26-000077
- Filed
- Jul 14, 2026, 3:34 PM ET
- Trade date
- Jul 13, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $615.1K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Blum Robert ICIK 0001288859 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 13, 2026 | Common Stock | SSaleDisposed | −10 | $82.02 | −$820.2 | 377,820 | Direct | |
| Jul 13, 2026 | Common Stock | MOption exerciseAcquired | +7,490 | $10.60 | +$79,394 | 385,310 | Direct | |
| Jul 13, 2026 | Common Stock | SSaleDisposed | −7,490 | $82.02 | −$614,329.8 | 377,820 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 13, 2026 | Common Stock | MOption exerciseDisposed | −7,490 | $0.00 | $0 | 186,745 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.